Back to search
FDAFDA · Food and drugs·Recall number Z-2267-2017

Pressure injectable Jugular Axillo-Subclavian Central CThe CG+Arrow JACC powered by Arrow VPS Stylet permits venous access to the central circulation through a central veinatheter (JACC) Product

Published June 14, 2017 · Recall initiated: March 20, 2017

Summary

FDA records medical device Class II recall Z-2267-2017, published June 14, 2017 and initiated March 20, 2017. Recalling firm: Arrow International Inc; Status: Terminated; Reported quantity: 43,394 units; Lot: Material Number CDC-41541-JX1A. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Arrow International initiated the recall due to reports of safety cover disengagement and needlestick injury for the BD Eclipse Needle that are packaged with certain Arrow products.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Arrow International Inc
Distributor
Nationwide Distribution
Lot
Material Number CDC-41541-JX1A
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Pressure injectable Jugular Axillo-Subclavian Central CThe CG+Arrow JACC powered by Arrow VPS Stylet permits venous access to the central circulation through a central veinatheter (JACC) Product recalled?

Yes. FDA published recall Z-2267-2017 on June 14, 2017. Reported hazard: Arrow International initiated the recall due to reports of safety cover disengagement and needlestick injury for the BD Eclipse Needle that are packaged with certain Arrow products.

What should I do if I have this product?

Voluntary: Firm initiated · Letter